Cargando…

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease

Predicting progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is clinically important. In this study, we propose a dual-model radiomic analysis with multivariate Cox proportional hazards regression models to investigate promising risk factors associated with MCI conversion to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Hucheng, Jiang, Jiehui, Lu, Jiaying, Wang, Min, Zhang, Huiwei, Zuo, Chuantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338093/ https://www.ncbi.nlm.nih.gov/pubmed/30686995 http://dx.doi.org/10.3389/fnins.2018.01045

Ejemplares similares

Radiomics: a novel feature extraction method for brain neuron degeneration disease using (18)F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment
por: Li, Yupeng, et al.
Publicado: (2019)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

Combining PET with MRI to improve predictions of progression from mild cognitive impairment to Alzheimer’s disease: an exploratory radiomic analysis study
por: Yang, Fan, et al.
Publicado: (2022)

Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
por: Wang, Min, et al.
Publicado: (2020)

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
por: Shen, Ting, et al.
Publicado: (2019)

A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
por: Wang, Min, et al.
Publicado: (2020)

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [(18)F]-APN-1607 Study
por: Zhang, Huiwei, et al.
Publicado: (2021)

Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Feng, Feng, et al.
Publicado: (2018)

Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia
por: Chen, Danyan, et al.
Publicado: (2019)

Brain Functional and Structural Signatures in Parkinson’s Disease
por: Liu, Chunhua, et al.
Publicado: (2020)

Hippocampus Radiomic Biomarkers for the Diagnosis of Amnestic Mild Cognitive Impairment: A Machine Learning Method
por: Feng, Qi, et al.
Publicado: (2019)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)

Deep Learning Model for Prediction of Progressive Mild Cognitive Impairment to Alzheimer’s Disease Using Structural MRI
por: Lim, Bing Yan, et al.
Publicado: (2022)

Glucose Metabolic Brain Network Differences between Chinese Patients with Lewy Body Dementia and Healthy Control
por: Chen, Danyan, et al.
Publicado: (2018)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

The Parkinson's Disease Progression Neuroimaging Initiative
por: Zhu, Shiyi, et al.
Publicado: (2021)

Editorial: Exploring Reliable Markers and Prediction Indexes for the Progression From Subjective Cognitive Decline to Cognitive Impairment
por: Jiang, Jiehui, et al.
Publicado: (2021)

Dual Tasking for the Differentiation between Depression and Mild Cognitive Impairment
por: Metzger, Florian G., et al.
Publicado: (2016)

Prediction of the progression from mild cognitive impairment to Alzheimer’s disease using a radiomics-integrated model
por: Shu, Zhen-Yu, et al.
Publicado: (2021)

The Specific Impact of Apolipoprotein E Epsilon 2 on Cognition and Brain Function in Cognitively Normal Elders and Mild Cognitive Impairment Patients
por: Gong, Liang, et al.
Publicado: (2020)

Are NSAIDs Useful to Treat Alzheimer's Disease or Mild Cognitive Impairment?
por: Imbimbo, Bruno P., et al.
Publicado: (2010)

The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis
por: Xing, Wenmin, et al.
Publicado: (2021)

Exercise-Induced Cognitive Plasticity, Implications for Mild Cognitive Impairment and Alzheimer’s Disease
por: Foster, Philip P., et al.
Publicado: (2011)

Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on (18)F-FDG PET Imaging
por: Zhou, Ping, et al.
Publicado: (2021)

Functional Connectivity Changes Across the Spectrum of Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Wang, Ziqi, et al.
Publicado: (2019)

Elevations in Serum Dickkopf-1 and Disease Progression in Community-Dwelling Older Adults With Mild Cognitive Impairment and Mild-to-Moderate Alzheimer’s Disease
por: Tay, Laura, et al.
Publicado: (2019)

Unlocking the enigma: unraveling multiple cognitive dysfunction linked to glymphatic impairment in early Alzheimer’s disease
por: Zhong, Jiayi, et al.
Publicado: (2023)

Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study
por: McNicholas, Kym, et al.
Publicado: (2022)

Improving CSF Biomarkers’ Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease by Considering Different Confounding Factors: A Meta-Analysis
por: Ferreira, Daniel, et al.
Publicado: (2014)

P300 and Neuropsychological Assessment in Mild Cognitive Impairment and Alzheimer Dementia
por: Parra, Mario A., et al.
Publicado: (2012)

Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
por: Guan, Jingjing, et al.
Publicado: (2020)

Editorial: Exploring reliable markers and prediction indexes for the progression from subjective cognitive decline to cognitive impairment, volume II
por: Jessen, Frank, et al.
Publicado: (2023)

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A (18)F-Florzolotau Study
por: Ju, Zizhao, et al.
Publicado: (2022)

Spatial Pattern Separation Testing Differentiates Alzheimer’s Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2021)

Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease
por: Kauppi, Karolina, et al.
Publicado: (2018)

Microstates as Disease and Progression Markers in Patients With Mild Cognitive Impairment
por: Musaeus, Christian Sandøe, et al.
Publicado: (2019)

The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Ling-Yun, et al.
Publicado: (2018)

Altered Functional Connectivity of the Basal Nucleus of Meynert in Subjective Cognitive Impairment, Early Mild Cognitive Impairment, and Late Mild Cognitive Impairment
por: Xu, Wenwen, et al.
Publicado: (2021)

Neural Correlates of Spatial Navigation Changes in Mild Cognitive Impairment and Alzheimer’s Disease
por: Vlček, Kamil, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_defl16i5ib11kg8dbvqbnl6b56